Pentobarbitone Induces Fos in Astrocytes: Increased Expression Following Picrotoxin and Seizures

Department of Medicine, Flinders University and Medical Centre, Adelaide, South Australia.
Experimental Neurology (Impact Factor: 4.7). 06/1996; 139(1):115-20. DOI: 10.1006/exnr.1996.0086
Source: PubMed


Fos immunoreactivity was observed in astrocytes identified by immunoreactivity to glial fibrillary acidic protein, 1.5 h following intravenous pentobarbitone anesthesia (20-30 mg/kg). Fos-positive astrocytes were seen only in the hilus of the hippocampus. Pentobarbitone administered after picrotoxin but without seizures resulted in an increase in both the intensity of Fos labeling and areal distribution of Fos-positive hilar astrocytes. Pentobarbitone administered after single picrotoxin-induced seizures resulted in an increased number of Fos immunoreactive astrocytes in the hilus and other hippocampal regions and their presence in the upper layers of Fr1, Fr2, cingulate, visual, and perirhinal cortex. Our observations that Fos is expressed in astrocytes following pentobarbitone, provides support for the current view that glial cell processes can be activated by pentobarbitone stimulation of GABAa receptor-chloride channels.

3 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: We determined the distribution of Fos protein expression in a model of generalised epilepsy caused by excessive neuronal excitation. Fos immunoreactivity was mapped in forebrain in unrestrained rats, previously prepared with an indwelling venous catheter, after the intravenous administration of kainic acid (10 mg/kg). We determined cerebral activation following various periods of exposure to kainic acid by using intravenous administration of pentobarbitone to prevent further activation. Within a few minutes, kainic acid caused episodes of staring, sniffing, wet dog shakes, nodding and chewing. Fos induction occurred initially and simultaneously in hippocampus, subiculum, septum and entorhinal cortex as early as 9.5 min after kainate injection. After up to 40 min of staring, sniffing, wet dog shakes, nodding and chewing, Fos induction was not further increased above levels present within the first 9.5 min. After 56 +/- 6 min a motor convulsion occurred, initially affecting the jaw, head and tail and variably extending to the forelimbs, trunk or hindlimbs. Following the convulsive event, additional Fos was expressed in hippocampus, thalamus, caudate-putamen and other subcortical structures and in the cerebral cortex. Fos induction was sometimes asymmetric in entorhinal, visual, piriform, cingulum, parietal and frontal cortices and in amygdala and dorsal endopiriform area. Electroencephalographic recordings after a few minutes exposure to kainic acid revealed an increased amplitude of fast frequencies in hippocampus which appeared to correlate with Fos induction in this structure. The findings are generally consistent with the reported distribution and slow development of kainic acid-induced seizure activity using electrophysiological and deoxyglucose methods. However, the Fos distribution suggests that (i) hippocampal, possibly dentate, activation precedes significant activation elsewhere, (ii) extensive involvement of other cerebral structures and cerebral cortex occurs simultaneously and correlates with motor seizures and (iii) brain structures can be recruited asymmetrically.
    Neuroscience 04/1997; 77(2):379-92. DOI:10.1016/S0306-4522(96)00462-9 · 3.36 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: One of the original views about motor convulsions with bilateral synchronous EEG discharges was that ascending projections from deep midline brainstem neurons subserve discharge synchronisation. We examined this in kainic acid- and picrotoxin-induced seizures using the distribution of Fos protein expression in the brainstem as a possible marker of brainstem neuronal activation. Before seizure, Fos was present in parabrachial nucleus, central grey and A1/C1 cell groups and, to a lesser extent, in A2/C2 cell groups and A6 neurons. Seizure correlated with further induction of Fos in these cell groups as well as in A6 neurons. There was no Fos in other cell groups with bilateral cerebro-cortical projections nor in cell groups likely to participate in the expression of seizures, reflecting a limitation of the Fos method. This study provides evidence of locus coeruleus involvement in these two models of seizure.
    Neuroscience Research 04/1999; 33(3-33):163-169. DOI:10.1016/S0168-0102(99)00008-5 · 1.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rationale: Studies of partial or generalized seizure pathophysiology often require the use of intact animals. Additionally, anesthesia may be required for ethical reasons or paralysis if instrumental measures require immobilization. We examined three commonly used injected anesthetic for their impact on seizures induced by three convulsant agents. Methods: We prepared rats, under pentobarbitone anesthesia (65 mg/kg) with a catheter, electrodes and a dural window, for later non-noxious experimentation. Three to seven days later, kainic acid (1.25 μg), picrotoxin (225 ng) or fluorocitrate (0.8 nmol) were injected intra-cortically in animals paralysed with succinylcholine, or anesthetised with pentobarbitone, urethane or fentanyl plus droperidol. We recorded EEG activity, the latencies to seizure discharges, the occurrence of spreading depressions and the presence of movements in response to the convulsants. Results: Fentanyl plus droperidol was the only anesthetic agent permissive for seizure-discharges and spreading depressions. No significant differences in the time for seizure onset for fentanyl plus droperidol compared to paralyzed unanesthetised rats were seen for any of the convulsants (Student's t-test p>0.20). Movements during seizures as well as other drug-induced behaviors continued to be expressed during anesthesia. Conclusion: Fentanyl plus droperidol has useful properties as an anesthetic agent in studies of seizure induction with different convulsants.
    Epilepsy research 01/2013; 105(1-2). DOI:10.1016/j.eplepsyres.2012.12.009 · 2.02 Impact Factor